ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,378.70
-0.61%
S&P ASX All Technology
3,885.10
-0.05%
Brent Oil
78.165
-0.22%
US Dollar vs AUD
1.59421
0.01%
Bitcoin
102,429.08
-1.16%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Evgen Pharma Plc (EVG) Share Price

Evgen Pharma Plc

Evgen Pharma Plc (EVG)

EVION Group NL
Evolving Gold Corp
Eaton Vance Short Duration Diversified Income Fund
0.80
0.00
(0.00%)
Closed 23 January 3:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.80
Bid
0.75
Offer
0.85
Volume
0.00
0.00 Day's Range 0.00
0.75 52 Week Range 1.85
Market Cap
2.199M
Previous Close
0.80
Open
-
Last Trade
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
0.00
Shares Outstanding
274,888,117
Dividend Yield
-
PE Ratio
-0.70
Earnings Per Share (EPS)
-0.01
Revenue
396k
Net Profit
-3.14M

About Evgen Pharma Plc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.theracryf.com
Headquarters
Cheshire, Gbr
Founded
-
Evgen Pharma Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker EVG. The last closing price for Evgen Pharma was 0.80p. Over the last year, Evgen Pharma shares have traded in a share price range of 0.75p to 1.85p.

Evgen Pharma currently has 274,888,117 shares in issue. The market capitalisation of Evgen Pharma is £2.20 million. Evgen Pharma has a price to earnings ratio (PE ratio) of -0.70.

Ask ADVFN Intelligence (AI)

EVG Latest News

More News

TRADING UPDATES: Norcros sells Johnson Tiles UK; Trifast trading well

The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by ...

26 April 2024
Alliance News

Evgen Pharma PLC Change of Name

Evgen Pharma PLC 25 April 2024     Evgen Pharma plc ("Evgen", the "Company" or the "Group")   Change of Name and Change of Company Website   Alderley Park, UK - 25 April 2024: Evgen Pharma plc...

26 April 2024
RNS Regulatory News

Evgen Pharma PLC Holding(s) in Company

Evgen Pharma PLC 22 April 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BSVYN304 Issuer Name EVGEN PHARMA PLC UK or Non-UK Issuer UK 2. Reason for...

22 April 2024
RNS Regulatory News

Evgen Pharma PLC Holding(s) in Company

Evgen Pharma PLC 11 April 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BSVYN304 Issuer Name EVGEN PHARMA PLC UK or Non-UK Issuer UK 2. Reason for...

12 April 2024
RNS Regulatory News

Evgen Pharma PLC Holding(s) in Company

Evgen Pharma PLC 09 April 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BSVYN304 Issuer Name EVGEN PHARMA PLC UK or Non-UK Issuer UK 2. Reason for...

09 April 2024
RNS Regulatory News

Evgen Pharma PLC Holding(s) in Company

Evgen Pharma PLC 08 April 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BSVYN304 Issuer Name EVGEN PHARMA PLC UK or Non-UK Issuer UK 2. Reason for...

09 April 2024
RNS Regulatory News

Evgen Pharma PLC Director/PDMR Shareholding

Evgen Pharma PLC 05 April 2024     Evgen Pharma plc ("Evgen", the "Company" or the "Group")   Director / PDMR Shareholding   5 April 2024 - Evgen Pharma plc (AIM: EVG), the clinical stage drug...

06 April 2024
RNS Regulatory News

Evgen Pharma PLC Holding(s) in Company

Evgen Pharma PLC 05 April 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN gb00bsvyn304 Issuer Name EVGEN PHARMA PLC UK or Non-UK Issuer UK 2. Reason for...

06 April 2024
RNS Regulatory News

TRADING UPDATES: Northcoders launches bootcamp; Schroder invests

The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by ...

05 April 2024
Alliance News

Evgen Pharma PLC Result of General Meeting

Evgen Pharma PLC 04 April 2024   4 April 2024 Evgen Pharma plc   ("Evgen", the "Company" or the "Group")   Result of General Meeting and Total Voting Rights   Evgen Pharma plc (AIM: EVG), the...

04 April 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.80.80.800DE
4000.80.80.800DE
12000.80.80.800DE
26000.80.80.800DE
52-0.8-501.61.850.753931751.15431861DE
156-4.15-83.83838383844.957.70.756577003.64816502DE
260-5.85-87.9699248126.6516.8250.7510297737.01474721DE

EVG - Frequently Asked Questions (FAQ)

What is the current Evgen Pharma share price?
The current share price of Evgen Pharma is 0.80p
How many Evgen Pharma shares are in issue?
Evgen Pharma has 274,888,117 shares in issue
What is the market cap of Evgen Pharma?
The market capitalisation of Evgen Pharma is GBP 2.2M
What is the 1 year trading range for Evgen Pharma share price?
Evgen Pharma has traded in the range of 0.75p to 1.85p during the past year
What is the PE ratio of Evgen Pharma?
The price to earnings ratio of Evgen Pharma is -0.7
What is the cash to sales ratio of Evgen Pharma?
The cash to sales ratio of Evgen Pharma is 5.71
What is the reporting currency for Evgen Pharma?
Evgen Pharma reports financial results in GBP
What is the latest annual turnover for Evgen Pharma?
The latest annual turnover of Evgen Pharma is GBP 396k
What is the latest annual profit for Evgen Pharma?
The latest annual profit of Evgen Pharma is GBP -3.14M
What is the registered address of Evgen Pharma?
The registered address for Evgen Pharma is ALDERLEY PARK, CONGLETON ROAD, NETHER ALDERLEY, CHESHIRE, SK10 4TG
What is the Evgen Pharma website address?
The website address for Evgen Pharma is www.theracryf.com
Which industry sector does Evgen Pharma operate in?
Evgen Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
EXREngage Xr Holdings Plc
2.00p
(190.91%)
94M
LLAILunglife Ai Inc
11.75p
(30.56%)
1.16M
TM1Technology Minerals Plc
0.14p
(27.27%)
78.39M
PYCPhysiomics Plc
1.05p
(27.27%)
41.18M
VASTVast Resources Plc
0.1325p
(26.19%)
245.04M
TRCThe Revel Collective Plc
0.275p
(-31.25%)
7.26M
MILAMila Resources Plc
0.225p
(-30.77%)
41.77M
MODER8 Capital Investments Plc
1.65p
(-26.67%)
5.59M
HOCHochschild Mining Plc
190.80p
(-16.68%)
9.86M
STKStreaksai Plc
1.05p
(-16.00%)
1.06M
NTVONativo Resources Plc
0.0021p
(5.00%)
1.33B
TRPTower Resources Plc
0.0295p
(-3.28%)
443.63M
PREMPremier African Minerals Limited
0.0255p
(-4.14%)
435.82M
SYMESupply@me Capital Plc
0.0031p
(-7.46%)
392.02M
RRRRed Rock Resources Plc
0.06p
(20.00%)
312.39M

Discussion

View Full Feed
jour_trader jour_trader 5 minutes ago
Minutes posted from call, but behind a paywall. 

https://www.pacermonitor.com/public/case/51356241/PURDUE_PHARMA_LP_et_al_v_ELITE_LABORATORIES_INC,_et_al
ELTP
ace65 ace65 11 minutes ago
When the pigs at the trough get their fill we will have a
HMBL type run.
And the pause of ongoing dilution of course.
HMBL
Dumb&dumber4long Dumb&dumber4long 11 minutes ago
Let’s focus on TNXP, stick politics somewhere else & other subjects too.
TNXP
22rover 22rover 12 minutes ago
It's important to remember that legacy holders have invested at or above 0.18 cents. If they are not following sidechannel’s progress, the reality they see is a thinly traded penny stock lingering near its all-time lows.

They phone their broker to sell the stock. Broker says, yeah, i
SDCH
pegs1 pegs1 12 minutes ago
I think it’s very unprofessional for management to not inform investors of the closing of the lab including departure of scientists! This just continues to be full of surprises ……
CRTG
gp22 gp22 14 minutes ago
ASNS: AI infrastructure stocks are getting hot coming off the massive $ORCL AI Infrastucture deal just announced.
$ASNS the cheapest microfloat AI Infrastructure stock. Top management. Starting to rip. Has recent upgrade from highly regarded Litchfield. Do not miss $ASNS.
$ASNS has 6K
ASNS BFAI ORCL
gp22 gp22 15 minutes ago
ASNS: AI infrastructure stocks are getting hot coming off the massive $ORCL AI Infrastucture deal just announced.
$ASNS the cheapest microfloat AI Infrastructure stock. Top management. Starting to rip. Has recent upgrade from highly regarded Litchfield. Do not miss $ASNS.
$ASNS has 6K
ASNS BFAI ORCL
gp22 gp22 15 minutes ago
ASNS: AI infrastructure stocks are getting hot coming off the massive $ORCL AI Infrastucture deal just announced.
$ASNS the cheapest microfloat AI Infrastructure stock. Top management. Starting to rip. Has recent upgrade from highly regarded Litchfield. Do not miss $ASNS.
$ASNS has 6K
ASNS BFAI ORCL
SkyLimit2022 SkyLimit2022 18 minutes ago
suit,

Thanks for posting the MHRA link!
https://investorshub.advfn.com/uimage/uploads/2024/10/21/zqal[200.gif
https://investorshub.advfn.com/uimage/uploads/2024/10/24/nqdtigiphy.gif

That’s exactly the kind of regulatory support that Advent has provided wh
NWBO
noradio noradio 19 minutes ago
Pm'd
DBMM
AlwaysOptimistic AlwaysOptimistic 19 minutes ago
I agree with you NorCal. Either the current mgt delivers financing this year or just sell the mine as you suggested to a large mining co that can deliver results. Many of us are stuck with shares that have fallen to lows that are not even worth selling. Would like to see a rebound and recoup our or
NB
The GidDy uP Kid The GidDy uP Kid 23 minutes ago
CNSP, readying for a Bullish Hammer tomorrow… 
https://schrts.co/cBIMqiew
CNSP
The GidDy uP Kid The GidDy uP Kid 23 minutes ago
CNSP, readying for a Bullish Hammer tomorrow… 
https://schrts.co/cBIMqiew
CNSP
The GidDy uP Kid The GidDy uP Kid 23 minutes ago
CNSP, readying for a Bullish Hammer tomorrow… 
https://schrts.co/cBIMqiew
CNSP
harry crumb harry crumb 25 minutes ago
Lets see 1.50 tomorrow or lower boys! Jam it at open! Lets roll $$$$$$
ILLR
XMaster2023 XMaster2023 25 minutes ago
Theory, Approval of DCVax is near!
NWBO
Plato_ Plato_ 26 minutes ago
Yup, that's the way I understand it. Whether the contract is paid up front or on performance, the revenue is recognized when earned and deferred revenue is reduced to match. Good example with the labor-based contract. Same principle. You make a good point about the intellectual property. If this is
GDVM
boi568 boi568 26 minutes ago
Statutes and regulations will always trump guidances, assuming the statutes or regulations address the issue the guidance is addressing. The reason agencies issue guidance is because the statutes and regulations haven't addressed the issue.

So, if you can find an FDA statute or regula
AVXL
boi568 boi568 26 minutes ago
Statutes and regulations will always trump guidances, assuming the statutes or regulations address the issue the guidance is addressing. The reason agencies issue guidance is because the statutes and regulations haven't addressed the issue.

So, if you can find an FDA statute or regula
AVXL
3331 3331 28 minutes ago
3331 has been restricted to one post per day:

BIEL HITS COPPER "IN THE BLINK OF AN EYE" WHEN THE FOLLOWING OCCURS!

pps > .001 after management drops some positive hints. The Golden Cross (already achieved) and Blue Sky Breakout will get the technicians/chartists attenti
QUBT SERV
theorysuit theorysuit 29 minutes ago
https://cms.mhra.gov.uk/mhra/mia/uk-miaimp-54923

Oh you are talking about this MIA. Unfortunately, i only see ADVENT on this MIA. No sight of NWBO at all. Like i said congrats to LP not NWBO.


https://find-and-update.company-information.service.gov.uk/company
NWBO
HomerRomer HomerRomer 30 minutes ago
This is a response to Missling’s LinkedIn post by a VERY educated and qualified senior vice president of Red Nucleus who manages and provides strategic oversight and tactical back up for clinical teams.  He seems to think Blarcamesine  could likely work better than the study results show. 
AVXL

Your Recent History

LSE
EVG
Evgen Pharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads